{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T05:43:51Z","timestamp":1759815831032,"version":"3.40.5"},"reference-count":7,"publisher":"FapUNIFESP (SciELO)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["An. Bras. Dermatol."],"published-print":{"date-parts":[[2013,8]]},"abstract":"<jats:p>Since its approval in 1997 by the FDA (United States Food and Drug Administration), rituximab has been used for certain B-cell lymphomas and treatment-resistant rheumatoid arthritis. Nevertheless, over the past 14 years, many case reports have demonstrated the efficacy of off-label rituximab in several dermatological inflammatory conditions. This study describes two cases of pemphigus vulgaris and two cases of pemphigus foliaceous that were treated with rituximab at 375 mg\/m2 once a week for 4 weeks, and that responded well to treatment.<\/jats:p>","DOI":"10.1590\/abd1806-4841.20131905","type":"journal-article","created":{"date-parts":[[2013,10,2]],"date-time":"2013-10-02T22:00:11Z","timestamp":1380751211000},"page":"676-678","source":"Crossref","is-referenced-by-count":12,"title":["Off-label use of rituximab in dermatology: pemphigus treatment"],"prefix":"10.1590","volume":"88","author":[{"given":"Lislaine","family":"Bomm","sequence":"first","affiliation":[{"name":"State University of Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tain\u00e1 Scalfoni","family":"Fracaroli","sequence":"additional","affiliation":[{"name":"University of the State of Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o Luz","family":"Sodr\u00e9","sequence":"additional","affiliation":[{"name":"State University of Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aline","family":"Bressan","sequence":"additional","affiliation":[{"name":"University of the State of Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandre Carlos","family":"Gripp","sequence":"additional","affiliation":[{"name":"University of the State of Rio de Janeiro, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1529-8019.2007.00141.x","article-title":"Off-label uses of rituximab in dermatology","volume":"20","author":"Carr DR","year":"2007","journal-title":"Dermatol Ther"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1111\/j.1365-4632.2006.03007.x","article-title":"Rituximab: applications in dermatology","volume":"45","author":"Fatourechi MM","year":"2006","journal-title":"Int J Dermatol"},{"key":"ref3","first-page":"29","article-title":"Rituximab: a review of dermatological applications","volume":"2","author":"Emer JJ","year":"2009","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.143.8.1033","article-title":"Treatment of severe pemphigus with rituximab","volume":"143","author":"Cianchini G","year":"2007","journal-title":"Arch Dermatol"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/j.1365-4632.2008.03682.x","article-title":"Treatment of refractory pemphigus erythematosus with rituximab","volume":"47","author":"Diab M","year":"2008","journal-title":"Int J Dermatol"},{"key":"ref6","first-page":"883","article-title":"The efficacy and safety of rituximab in refractory pemphigus: a review of case reports","volume":"6","author":"Allen KJ","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"321950","DOI":"10.1155\/2010\/321950","article-title":"Targeted immunotherapy with rituximab leads to a transient alteration of the IgG autoantibody profile in pemphigus vulgaris","volume":"2010","author":"M\u00fcller R","year":"2010","journal-title":"Dermatol Res Pract"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/pdf\/abd\/v88n4\/0365-0596-abd-88-4-0676.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,19]],"date-time":"2025-05-19T15:00:42Z","timestamp":1747666842000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0365-05962013000400676&lng=en&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S0365-05962013000400676"],"URL":"https:\/\/doi.org\/10.1590\/abd1806-4841.20131905","relation":{},"ISSN":["0365-0596"],"issn-type":[{"type":"electronic","value":"0365-0596"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}